These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27237103)

  • 1. Is Total Risk Management an Answer for Better Prognosis in Diabetic Patients?
    Sakakura K
    J Atheroscler Thromb; 2016 Aug; 23(8):903-4. PubMed ID: 27237103
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of Total Risk Management on Coronary Plaque Regression in Diabetic Patients with Acute Coronary Syndrome.
    Naito R; Miyauchi K; Daida H; Morimoto T; Hiro T; Kimura T; Nakagawa Y; Yamagishi M; Ozaki Y; Matsuzaki M;
    J Atheroscler Thromb; 2016 Aug; 23(8):922-31. PubMed ID: 26961111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Requiem for the 'vulnerable plaque'.
    Libby P; Pasterkamp G
    Eur Heart J; 2015 Nov; 36(43):2984-7. PubMed ID: 26206212
    [No Abstract]   [Full Text] [Related]  

  • 4. [Stabilization of vulnerable coronary plaque].
    Chibana H; Mitsutake Y; Itaya N; Ueno T
    Nihon Rinsho; 2011 Nov; 69 Suppl 9():306-10. PubMed ID: 22724220
    [No Abstract]   [Full Text] [Related]  

  • 5. Qualitative plaque stabilization but not quantitative plaque regression.
    Nishigaki K
    Circ J; 2012; 76(4):809-11. PubMed ID: 22451448
    [No Abstract]   [Full Text] [Related]  

  • 6. [Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome (JAPAN-aCS) study].
    Takeuchi T; Ota H; Hasebe N
    Nihon Rinsho; 2011 Nov; 69 Suppl 9():336-40. PubMed ID: 22724225
    [No Abstract]   [Full Text] [Related]  

  • 7. [Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH study].
    Miyauchi K
    Nihon Rinsho; 2011 Nov; 69 Suppl 9():321-30. PubMed ID: 22724223
    [No Abstract]   [Full Text] [Related]  

  • 8. More intensive lipid lowering is associated with regression of coronary atherosclerosis in diabetic patients with acute coronary syndrome--sub-analysis of JAPAN-ACS study.
    Arai H; Hiro T; Kimura T; Morimoto T; Miyauchi K; Nakagawa Y; Yamagishi M; Ozaki Y; Kimura K; Saito S; Yamaguchi T; Daida H; Matsuzaki M;
    J Atheroscler Thromb; 2010 Oct; 17(10):1096-107. PubMed ID: 20675955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The need to improve cardiac care after acute coronary syndrome.
    Kolovou G
    Hellenic J Cardiol; 2019; 60(4):254-255. PubMed ID: 31901256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between circulating matrix metalloproteinase levels and coronary plaque regression after acute coronary syndrome--subanalysis of the JAPAN-ACS study.
    Ogita M; Miyauchi K; Morimoto T; Daida H; Kimura T; Hiro T; Nakagawa Y; Yamagishi M; Ozaki Y; Matsuzaki M
    Atherosclerosis; 2013 Jan; 226(1):275-80. PubMed ID: 23159100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-intensity statin therapy alters the natural history of diabetic coronary atherosclerosis: insights from SATURN.
    Stegman B; Puri R; Cho L; Shao M; Ballantyne CM; Barter PJ; Chapman MJ; Erbel R; Libby P; Raichlen JS; Uno K; Kataoka Y; Nissen SE; Nicholls SJ
    Diabetes Care; 2014 Nov; 37(11):3114-20. PubMed ID: 25190674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the unstable plaque in acute coronary syndromes.
    Thompson PL; Nidorf SM; Eikelboom J
    Clin Ther; 2013 Aug; 35(8):1099-107. PubMed ID: 23973042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status of lipid management in acute coronary syndrome.
    Fujisue K; Tsujita K
    J Cardiol; 2017 Aug; 70(2):101-106. PubMed ID: 28325524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is clonal hematopoiesis a new risk factor for cardiovascular diseases?: Clinical and experimental evidences.
    Páramo Fernandez JA
    Med Clin (Barc); 2018 Sep; 151(5):207-209. PubMed ID: 29802011
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug therapy of diabetic dyslipidemia: do the statins suffice?
    Mooradian AD
    Am J Ther; 2015; 22(1):87-8. PubMed ID: 23728161
    [No Abstract]   [Full Text] [Related]  

  • 16. Diabetes mellitus is a major negative determinant of coronary plaque regression during statin therapy in patients with acute coronary syndrome--serial intravascular ultrasound observations from the Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome Trial (the JAPAN-ACS Trial).
    Hiro T; Kimura T; Morimoto T; Miyauchi K; Nakagawa Y; Yamagishi M; Ozaki Y; Kimura K; Saito S; Yamaguchi T; Daida H; Matsuzaki M;
    Circ J; 2010 Jun; 74(6):1165-74. PubMed ID: 20467151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Finally: the proof of concept--from animal studies, imaging and the clinical evidence of plaque rupture.
    Moriguchi E
    Atherosclerosis; 2010 Dec; 213(2):367-8. PubMed ID: 20970136
    [No Abstract]   [Full Text] [Related]  

  • 18. Who benefits from statins? Patient or focal plaque?
    Fujii K; Masuyama T
    Circ J; 2012; 76(12):2744-5. PubMed ID: 23117744
    [No Abstract]   [Full Text] [Related]  

  • 19. Cerivastatin, a hydroxymethylglutaryl coenzyme a reductase inhibitor, improves endothelial function in elderly diabetic patients within 3 days.
    Hashimoto M; Akita H
    Circulation; 2002 Jan; 105(4):E30-1. PubMed ID: 11815444
    [No Abstract]   [Full Text] [Related]  

  • 20. Changes in coronary plaque morphology in patients with acute coronary syndrome versus stable angina pectoris after initiation of statin therapy.
    Gin AL; Vergallo R; Minami Y; Ong DS; Hou J; Jia H; Soeda T; Hu S; Zhang S; Lee H; Yu B; Jang IK
    Coron Artery Dis; 2016 Dec; 27(8):629-635. PubMed ID: 27468140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.